Annual Operating Profit
-$10.65 M
-$750.00 K-7.58%
December 31, 2022
Summary
- As of February 10, 2025, NVIV annual operating income is -$10.65 million, with the most recent change of -$750.00 thousand (-7.58%) on December 31, 2022.
- During the last 3 years, NVIV annual operating profit has risen by +$847.00 thousand (+7.37%).
Performance
NVIV Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Profit
-$2.83 M
-$743.00 K-35.64%
September 30, 2023
Summary
- As of February 10, 2025, NVIV quarterly operating income is -$2.83 million, with the most recent change of -$743.00 thousand (-35.64%) on September 30, 2023.
- Over the past year, NVIV quarterly operating profit has dropped by -$28.00 thousand (-1.00%).
Performance
NVIV Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Operating Profit
-$9.86 M
-$28.00 K-0.28%
September 30, 2023
Summary
- As of February 10, 2025, NVIV TTM operating income is -$9.86 million, with the most recent change of -$28.00 thousand (-0.28%) on September 30, 2023.
- Over the past year, NVIV TTM operating profit has increased by +$1.25 million (+11.27%).
Performance
NVIV TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
NVIV Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.6% | -1.0% | +11.3% |
| 3 y3 years | +7.4% | -23.9% | -2.2% |
| 5 y5 years | +56.7% | -33.8% | +14.3% |
NVIV Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +7.6% | at low | +35.6% | +3.0% | +0.3% | +12.7% |
| 5 y | 5-year | +17.1% | +8.0% | +35.6% | +3.0% | +10.8% | +16.6% |
| alltime | all time | >+9999.0% | +130.9% | <-9999.0% | +144.9% | >+9999.0% | +171.3% |
InVivo Therapeutics Holdings Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$2.83 M(+35.6%) | -$9.86 M(+0.3%) |
| Jun 2023 | - | -$2.08 M(-16.2%) | -$9.83 M(-6.2%) |
| Mar 2023 | - | -$2.49 M(+1.3%) | -$10.47 M(-1.7%) |
| Dec 2022 | -$10.65 M(+7.6%) | -$2.46 M(-12.3%) | -$10.65 M(-4.1%) |
| Sep 2022 | - | -$2.80 M(+2.6%) | -$11.11 M(+3.2%) |
| Jun 2022 | - | -$2.73 M(+2.4%) | -$10.76 M(+4.1%) |
| Mar 2022 | - | -$2.67 M(-8.5%) | -$10.34 M(+4.5%) |
| Dec 2021 | -$9.90 M(+8.8%) | -$2.91 M(+18.8%) | -$9.90 M(+7.9%) |
| Sep 2021 | - | -$2.45 M(+6.2%) | -$9.18 M(+1.9%) |
| Jun 2021 | - | -$2.31 M(+3.9%) | -$9.01 M(+1.3%) |
| Mar 2021 | - | -$2.22 M(+1.5%) | -$8.89 M(-2.2%) |
| Dec 2020 | -$9.10 M(-20.9%) | -$2.19 M(-4.0%) | -$9.10 M(-5.7%) |
| Sep 2020 | - | -$2.28 M(+4.0%) | -$9.64 M(-4.4%) |
| Jun 2020 | - | -$2.19 M(-9.6%) | -$10.09 M(-9.4%) |
| Mar 2020 | - | -$2.43 M(-11.4%) | -$11.15 M(-3.0%) |
| Dec 2019 | -$11.50 M(-9.9%) | -$2.74 M(+0.3%) | -$11.50 M(-2.3%) |
| Sep 2019 | - | -$2.73 M(-15.9%) | -$11.77 M(+5.6%) |
| Jun 2019 | - | -$3.25 M(+16.9%) | -$11.15 M(+4.1%) |
| Mar 2019 | - | -$2.78 M(-7.7%) | -$10.71 M(-16.1%) |
| Dec 2018 | -$12.77 M(-48.1%) | -$3.01 M(+42.5%) | -$12.77 M(-11.6%) |
| Sep 2018 | - | -$2.11 M(-24.9%) | -$14.44 M(-22.5%) |
| Jun 2018 | - | -$2.81 M(-41.8%) | -$18.64 M(-18.1%) |
| Mar 2018 | - | -$4.83 M(+3.2%) | -$22.76 M(-7.5%) |
| Dec 2017 | -$24.59 M(+2.2%) | -$4.68 M(-25.9%) | -$24.59 M(-8.0%) |
| Sep 2017 | - | -$6.32 M(-8.8%) | -$26.74 M(+1.7%) |
| Jun 2017 | - | -$6.93 M(+3.9%) | -$26.30 M(+4.5%) |
| Mar 2017 | - | -$6.67 M(-2.4%) | -$25.16 M(+4.6%) |
| Dec 2016 | -$24.06 M(+7.4%) | -$6.83 M(+16.2%) | -$24.06 M(+7.0%) |
| Sep 2016 | - | -$5.88 M(+1.6%) | -$22.49 M(+0.0%) |
| Jun 2016 | - | -$5.79 M(+3.9%) | -$22.48 M(+0.1%) |
| Mar 2016 | - | -$5.57 M(+5.9%) | -$22.45 M(+0.3%) |
| Dec 2015 | -$22.40 M(+25.6%) | -$5.26 M(-10.4%) | -$22.40 M(+6.7%) |
| Sep 2015 | - | -$5.87 M(+1.9%) | -$20.98 M(+8.7%) |
| Jun 2015 | - | -$5.76 M(+4.5%) | -$19.30 M(+5.6%) |
| Mar 2015 | - | -$5.51 M(+43.4%) | -$18.28 M(+2.5%) |
| Dec 2014 | -$17.84 M | -$3.84 M(-8.1%) | -$17.84 M(-9.3%) |
| Sep 2014 | - | -$4.18 M(-11.7%) | -$19.67 M(-5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$4.74 M(-6.5%) | -$20.89 M(-1.6%) |
| Mar 2014 | - | -$5.07 M(-10.6%) | -$21.23 M(+11.7%) |
| Dec 2013 | -$19.00 M(+48.7%) | -$5.67 M(+5.0%) | -$19.00 M(+5.3%) |
| Sep 2013 | - | -$5.41 M(+6.6%) | -$18.05 M(+16.6%) |
| Jun 2013 | - | -$5.07 M(+77.9%) | -$15.49 M(+17.6%) |
| Mar 2013 | - | -$2.85 M(-39.6%) | -$13.17 M(+3.1%) |
| Dec 2012 | -$12.78 M(+47.6%) | -$4.72 M(+66.2%) | -$12.78 M(+20.9%) |
| Sep 2012 | - | -$2.84 M(+3.1%) | -$10.57 M(+6.3%) |
| Jun 2012 | - | -$2.76 M(+12.0%) | -$9.95 M(+2.3%) |
| Mar 2012 | - | -$2.46 M(-2.2%) | -$9.72 M(+12.2%) |
| Dec 2011 | -$8.66 M(+154.9%) | -$2.52 M(+13.7%) | -$8.66 M(+41.0%) |
| Sep 2011 | - | -$2.21 M(-12.4%) | -$6.14 M(+55.4%) |
| Jun 2011 | - | -$2.53 M(+80.4%) | -$3.95 M(+172.4%) |
| Mar 2011 | - | -$1.40 M(+5809.7%) | -$1.45 M(+2209.7%) |
| Dec 2010 | -$3.40 M(+5955.8%) | - | - |
| Sep 2010 | - | -$23.70 K(-9.5%) | -$62.80 K(+31.4%) |
| Jun 2010 | - | -$26.20 K(+285.3%) | -$47.80 K(-14.8%) |
| Mar 2010 | - | -$6800.00(+11.5%) | -$56.10 K(-35.7%) |
| Mar 2010 | -$56.10 K(-13.0%) | - | - |
| Dec 2009 | - | -$6100.00(-29.9%) | -$87.30 K(+3.4%) |
| Sep 2009 | - | -$8700.00(-74.8%) | -$84.40 K(+16.3%) |
| Jun 2009 | - | -$34.50 K(-9.2%) | -$72.60 K(+24.5%) |
| Mar 2009 | -$64.50 K(+81.2%) | -$38.00 K(+1087.5%) | -$58.30 K(+24.8%) |
| Dec 2008 | - | -$3200.00(-203.2%) | -$46.70 K(-6.8%) |
| Sep 2008 | - | $3100.00(-115.3%) | -$50.10 K(-5.8%) |
| Jun 2008 | - | -$20.20 K(-23.5%) | -$53.20 K(+43.0%) |
| Mar 2008 | -$35.60 K(-92.1%) | -$26.40 K(+300.0%) | -$37.20 K(-89.6%) |
| Dec 2007 | - | -$6600.00(<-9900.0%) | -$358.20 K(-7.0%) |
| Sep 2007 | - | $0.00(-100.0%) | -$385.30 K(-11.6%) |
| Jun 2007 | - | -$4200.00(-98.8%) | -$436.10 K(-3.5%) |
| Mar 2007 | -$452.00 K(+1225.5%) | -$347.40 K(+930.9%) | -$452.10 K(+259.1%) |
| Dec 2006 | - | -$33.70 K(-33.7%) | -$125.90 K(+29.4%) |
| Sep 2006 | - | -$50.80 K(+151.5%) | -$97.30 K(+88.2%) |
| Jun 2006 | - | -$20.20 K(-4.7%) | -$51.70 K(+64.1%) |
| Mar 2006 | -$34.10 K | -$21.20 K(+315.7%) | -$31.50 K(+205.8%) |
| Dec 2005 | - | -$5100.00(-1.9%) | -$10.30 K(+98.1%) |
| Sep 2005 | - | -$5200.00 | -$5200.00 |
FAQ
- What is InVivo Therapeutics Holdings annual operating income?
- What is the all time high annual operating profit for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings annual operating profit year-on-year change?
- What is InVivo Therapeutics Holdings quarterly operating income?
- What is the all time high quarterly operating profit for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings quarterly operating profit year-on-year change?
- What is InVivo Therapeutics Holdings TTM operating income?
- What is the all time high TTM operating profit for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings TTM operating profit year-on-year change?
What is InVivo Therapeutics Holdings annual operating income?
The current annual operating profit of NVIV is -$10.65 M
What is the all time high annual operating profit for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high annual operating income is -$34.10 K
What is InVivo Therapeutics Holdings annual operating profit year-on-year change?
Over the past year, NVIV annual operating income has changed by -$750.00 K (-7.58%)
What is InVivo Therapeutics Holdings quarterly operating income?
The current quarterly operating profit of NVIV is -$2.83 M
What is the all time high quarterly operating profit for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high quarterly operating income is $3100.00
What is InVivo Therapeutics Holdings quarterly operating profit year-on-year change?
Over the past year, NVIV quarterly operating income has changed by -$28.00 K (-1.00%)
What is InVivo Therapeutics Holdings TTM operating income?
The current TTM operating profit of NVIV is -$9.86 M
What is the all time high TTM operating profit for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high TTM operating income is -$5200.00
What is InVivo Therapeutics Holdings TTM operating profit year-on-year change?
Over the past year, NVIV TTM operating income has changed by +$1.25 M (+11.27%)